Dxcover
Latest round
- Series A
Last raised
- Jan 2023
Total raised
- $9.3M
Investors
- 6
About Dxcover
Based in Glasgow, UK, and founded in 2016, Dxcover Limited, fka Clinspec Diagnostics Limited is a clinical-stage liquid biopsy company that operates as a manufacturer of a diagnostic device that helps medical experts detect cancer by using blood as a sample. Mark Hegarty (CEO) and Matthew J. Baker (CTO) are the co-founders of the company. ClinSpec Diagnostics Limited was spun off from the University of Strathclyde in 2019 and rebranded as Dxcover Limited in 2021. The company develops the Dxcover Platform, a system that analyzes a patient's blood serum to detect the presence or absence of disease and combines hardware with advanced artificial intelligence algorithms. The platform combines infrared spectroscopy with artificial intelligence to achieve same-day detection of cancer from a simple blood sample, enabling rapid diagnosis and stratification of patients for earlier treatment. In addition, the business develops Dxcover brain cancer liquid biopsy, a technology that gives clinicians a tool for spotting brain cancer. Dxcover is also developing a set of tests to identify the most prevalent cancers by utilizing its Dxcover platform and drop-dry-detect approach.
Who invested in Dxcover
6 investors across 1 round
See all investors in Dxcover
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 27, 2023
Amount
$9.3M
Investors
Questions about Dxcover
Who invested in Dxcover?
Dxcover has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dxcover raised?
Dxcover has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Dxcover last raise money?
Dxcover's most recent round on record is a Series A, in Jan 2023.
What does Dxcover do?
Based in Glasgow, UK, and founded in 2016, Dxcover Limited, fka Clinspec Diagnostics Limited is a clinical-stage liquid biopsy company that operates as a manufacturer of a diagnostic device that helps medical experts detect cancer by using blood as a sample.
Where is Dxcover headquartered?
Dxcover is headquartered in Glasgow, UK.
Which VCs invest in companies like Dxcover?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back medical devices & equipment companies at Dxcover's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Dxcover? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.